Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Stickler Syndrome

Connective Tissue & Musculoskeletal

Stickler Syndrome Clinical Trials and Treatments

Also called hereditary arthro-ophthalmopathy, COL2A1 mutation, progressive arthritis

Stickler syndrome is a rare autosomal dominant connective tissue disorder caused by mutations in genes encoding type II collagen or related proteins (primarily COL2A1, COL11A1, COL11A2, and other genes affecting extracellular matrix). The underlying defect affects structural proteins essential for tissues requiring significant mechanical strength and flexibility including the eyes, joints, and ears.

In plain words, Stickler syndrome is a rare inherited condition that affects collagen, a protein that gives the body strength and stretch. Because of this, people can have serious nearsightedness and hearing loss along with joint problems that worsen over time.

Get an email when new Stickler Syndrome trials open or the FDA decides. Get alerts

Stickler Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 2 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Stickler Syndrome yet.

Stickler Syndrome has no FDA-approved medicines, 2 open or active clinical trials (2 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

Latest for Stickler Syndrome

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Stickler Syndrome

Ocular manifestations are prominent and often the presenting feature, including high myopia (often >-3 diopters), vitreous abnormalities (liquefaction, opacification, floaters), retinal detachment risk (73% of untreated adults with type 1 Stickler syndrome in one large UK study), and progressive cataracts. Progressive osteoarthritis develops in large joints (knees, hips, shoulders, elbows) often beginning in adolescence or young adulthood, becoming increasingly disabling with age.

Keep reading about Stickler Syndrome

Sensorineural hearing loss occurs due to abnormal cochlear development and ranges from mild to profound; approximately 75% of patients demonstrate some degree of hearing impairment. Midface hypoplasia with micrognathia characterizes the facial appearance; cleft palate occurs in 25-30% of patients. Progressive nature of joint and ocular disease can lead to significant disability without early intervention and management. Genetic testing confirms diagnosis and enables family screening of asymptomatic at-risk relatives.

What are the symptoms of Stickler Syndrome?

These are common symptoms of Stickler Syndrome, and how strong they are varies from person to person.

  • Severe myopia and vision problems
  • Vitreous floaters and liquefaction
  • Progressive joint disease and arthritis
  • Sensorineural hearing loss
  • Cleft palate in some cases
  • Midface hypoplasia

Who gets Stickler Syndrome?

Typically manifests in infancy or early childhood with vision and hearing abnormalities becoming apparent during developmental screening or when functional limitations emerge. Affects males and females equally with no gender predominance. Autosomal dominant inheritance is most common (COL2A1, COL11A1 and COL11A2), and each child of an affected parent has a 50% chance of inheriting the variant.

Rare autosomal recessive forms reported with specific COL9A genes. No significant ethnic or racial differences in prevalence documented. Disease manifestations begin early but progressive nature means functional impact increases with age. Some cases come from a new variant with no family history.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Stickler Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Stickler Syndrome resources

Reputable organizations and medical references for learning more about Stickler Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Stickler Syndrome

Use this Stickler Syndrome clinical trial finder to see the 2 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 1 tests a treatment and 1 is an observational study or registry; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

2 active trials worldwide
Filter:
Sort:
RecruitingPatient registry covering many conditionsRecently updatedNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Sponsor: Sanford Health

The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute...

Ages not specified1 location
Started Jul 2010Updated 3 weeks agoEst. Dec 2100 (~74y 2m)
RecruitingTreatment trialRecently updatedNCT07146516

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

Intervention: Prophylactic (non-invasive) Laser Retinopexy

Sponsor: Helen Keller Eye Research Foundation

The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults.

Ages not specified
Started Oct 2025Updated 3 weeks agoEst. Dec 2035 (~9y 1m)
Find Stickler Syndrome trials near you, ranked by distance →
Active trial locations7 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Stickler Syndrome trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Stickler Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Stickler Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Stickler Syndrome patients, caregivers and advocacy groups talk.

Questions people ask about Stickler Syndrome